American Gene Technologies International Stock

americangene.comBioTechFounded: 2007Funding to Date: $54.88MM

American Gene Technologies ("AGT") is an emerging gene and cell therapeutics company with a proprietary lentiviral platform capable of broad applications including large and orphan indications, infectious disease, immune-oncology, and monogenic disorders.

Enterprise Value (based on primary financings)

Register for Details

For more details on financing and valuation for American Gene Technologies International, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Team

Management Team

Jeffrey Galvin
Co-Founder, Chief Executive Officer & Board Member
Neil Lyons
Chief Financial Officer & Executive Vice President
David Pauza Ph.D
Chief Science Officer
Norman Rogers
Executive, Business Development

Board Members

Aaron Galvin
Jeffrey Galvin
Julia Brown
Qi Tang
Tommy Thompson JD

Other companies like American Gene Technologies International in the BioTech sector

Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.89B
Sector
Last Round Est. Valuation
$872.62MM
Sector
Last Round Est. Valuation
$486.63MM
Sector
Last Round Est. Valuation
$186.12MM
Sector
Last Round Est. Valuation
$50.4MM
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$185MM